510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0729-2017Class II

Merge Cardio software. Merge Cardio is a system intended to be used to acquire, store, print, transfer, and...

Merge Healthcare Incorporated / initiated 2016-03-28 / Terminated / root cause: software

Merge Healthcare, Inc. began a recall of Merge Cardio software. Merge Cardio is a system intended to be used to acquire, store, print, transfer, and archive clinical information including images... on . FDA classified it as Class II and gives the reason as "If images are sent without an order in the system, they will be matched with the latest order on the current patient/modality matching potentially resulting in the matching of the report to the incorrect accession...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-0729-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Merge Healthcare Incorporated
Product
Merge Cardio software. Merge Cardio is a system intended to be used to acquire, store, print, transfer, and archive clinical information including images, Hemodynamic studies and reports, measurements (via import from DICOM Structured Reporting, text files or optical character recognition of measurements captured on images) and cardiology signal (waveform) data.
Product code
LLZ System, Image Processing, Radiological
Reason for recall
If images are sent without an order in the system, they will be matched with the latest order on the current patient/modality matching potentially resulting in the matching of the report to the incorrect accession number (but still associated to the correct patient).
Root cause tag
software
FDA root cause
Software design
Action
MERE sent an Urgent Medical Device Recall letter dated July 11, 2016, to all affected customers via email or via certified mail if they did not have an email address for the customer. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to respond to the notification using the enclosed form and the return addressed envelope. Customers were also instructed to ensure that all users of the product are provided with the notification and if product was further distributed customers need to identify their customers and notify them at once of the product recall. Customers with questions should send an email to [email protected]. For questions regarding this recall call 877-741-5369.
Quantity in commerce
198 sites potentially have the effected versions
Distribution
Nationwide Distribution
Product codes and lots
Versions:  8.30.0, 8.30.1, 9.0, 9.0.1, 9.0.2, 9.0.3, 9.0.4, 9.0.5, 9.0.6, 9.0.7, 9.0.8, 9.0.9, 10.0, 10.0.1, 10.1, and 10.1.1

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0729-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0729-2017Class IITerminatedVoluntary: Firm initiated